Stoke Therapeutics Inc (NASDAQ:STOK)

Delayed Data
As of Dec 08
 +0.17 / +3.70%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 18.00, with a high estimate of 35.00 and a low estimate of 6.00. The median estimate represents a +278.15% increase from the last price of 4.76.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.32%
Growthannually 4.57%


Growthquarterly 15.81%
Growthannually 15.04%
Key to the earnings and sales forecast charts.